2016
DOI: 10.1371/journal.pone.0160248
|View full text |Cite|
|
Sign up to set email alerts
|

Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Our findings, overall, indicate replication fork collapse due to DPS-2 treatment, still, further investigation is needed to understand how the compound affects the signaling pathways involved in cellular survival and death, in particular in view of DPS-2’s development as a novel chemotherapeutic drug. Chemotherapeutic agents may activate various modes of cell death and, in general, the cell death pathways finally activated following the interplay of pro-survival and pro-death signaling depend on the cellular background [17,44]. In cancer cell systems, the evasion of cell death being one of the major hallmarks, this interplay becomes even more complicated [20].…”
Section: Discussionmentioning
confidence: 99%
“…Our findings, overall, indicate replication fork collapse due to DPS-2 treatment, still, further investigation is needed to understand how the compound affects the signaling pathways involved in cellular survival and death, in particular in view of DPS-2’s development as a novel chemotherapeutic drug. Chemotherapeutic agents may activate various modes of cell death and, in general, the cell death pathways finally activated following the interplay of pro-survival and pro-death signaling depend on the cellular background [17,44]. In cancer cell systems, the evasion of cell death being one of the major hallmarks, this interplay becomes even more complicated [20].…”
Section: Discussionmentioning
confidence: 99%